Работы, на которые ссылается эта работа

Работ: 262

Работа: Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun +1
Обзорная статья2022Цитирований: 2
ABI
Towards precision medicine using biochemically triggered cleavable conjugation
Badri Parshad, Smriti Arora, Balram Singh +4
Обзорная статья2025Цитирований: 2
ABI
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham, Jérôme Alexandre, Peng Huang
Обзорная статья2009Цитирований: 2
ABI
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce, Douglas T. Fearon
Обзорная статья2015Цитирований: 2
ABI
Enzyme-responsive nanomaterials for controlled drug delivery
Quanyin Hu, Prateek S. Katti, Zhen Gu
Обзорная статья2014Цитирований: 2
ABI
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm, Anthony J. Tavares, Qin Dai +4
Обзорная статья2016Цитирований: 2
ABI
Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges
Gurusamy Saravanakumar, Jihoon Kim, Won Jong Kim
Обзорная статья2016Цитирований: 2
ABI
Elements of cancer immunity and the cancer–immune set point
Daniel S. Chen, Ira Mellman
Обзорная статья2017Цитирований: 2
ABI
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Shu Yang, Huile Gao
Обзорная статья2017Цитирований: 2
ABI
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith +43
Статья2017Цитирований: 2
ABI
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan, Shannon J. Turley, Dorothee Nickles +39
Статья2018Цитирований: 2
ABI
Defining ‘T cell exhaustion’
Christian U. Blank, W. Nicholas Haining, Werner Held +15
Обзорная статья2019Цитирований: 2
ABI
The dose threshold for nanoparticle tumour delivery
Ben Ouyang, Wilson Poon, Yi-Nan Zhang +11
Статья2020Цитирований: 2
ABI
Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
Satyen H. Gohil, J. Bryan Iorgulescu, David A. Braun +2
Обзорная статья2020Цитирований: 2
ABI
Off-the-Shelf Chimeric Antigen Receptor T Cells
Norihiro Watanabe, Maksim Mamonkin
Обзорная статья2021Цитирований: 2
ABI
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
Zowi R. Huinen, Elisabeth J. M. Huijbers, Judy R. van Beijnum +2
Обзорная статья2021Цитирований: 2
ABI
Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines
Mirjam E. Hoekstra, Saskia V Vijver, Ton N. Schumacher
Обзорная статья2021Цитирований: 2
ABI
In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response
Worapol Ngamcherdtrakul, Moataz Reda, Molly A. Nelson +11
Статья2021Цитирований: 2
ABI
Hypoxia and the Tumor Microenvironment
Yue Li, Long Zhao, Xiaofeng Li
Обзорная статья2021Цитирований: 2
ABI
Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy
Yao Xiao, Tian Zhang, Xianbin Ma +6
Статья2021Цитирований: 2
ABI
Desmoplastic Reaction, Immune Cell Response, and Prognosis in Colorectal Cancer
Naohiko Akimoto, Juha P. Väyrynen, Melissa Zhao +18
Статья2022Цитирований: 2
ABI
NIR/pH-responsive chitosan hydrogels containing Ti3C2/AuNRs with NIR-triggered photothermal effect
Chongchong Liu, Panping Yang, Jingguo Li +2
Статья2022Цитирований: 2
ABI
Reactive oxygen species-responsive polymer drug delivery systems
Jiaxue Liu, Boyan Jia, Zhibo Li +1
Обзорная статья2023Цитирований: 2
ABI
<scp>pH</scp>‐responsive polymers for drug delivery: Trends and opportunities
Jagtar Singh, Pallavi Nayak
Статья2023Цитирований: 2
ABI
The cancer-immunity cycle: Indication, genotype, and immunotype
Ira Mellman, Daniel S. Chen, Thomas Powles +1
Обзорная статья2023Цитирований: 2
ABI